{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:49:34Z","timestamp":1790027374745,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mbc.0b013e328359bc59","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T19:08:56Z","timestamp":1350587336000},"page":"97-99","source":"Crossref","is-referenced-by-count":7,"title":["Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma"],"prefix":"10.1097","volume":"24","author":[{"given":"Ahmadinejad","family":"Minoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roushan","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210203","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00277-007-0408-1","article-title":"Pericardial effusion in a patient with acquired factor V inhibitor.","volume":"87","author":"Bulcao Macedo","year":"2008","journal-title":"Ann Hematol"},{"key":"R2-18-20210203","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/gut.2005.076232","article-title":"Acquired factor V inhibitor associated with valproic acid use in a cirrhotic patient.","volume":"55","author":"Godart","year":"2006","journal-title":"Gut"},{"key":"R3-18-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0950-3536(98)80050-4","article-title":"Acquired factor V inhibitors.","volume":"11","author":"Knobl","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"R4-18-20210203","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00001721-200412000-00003","article-title":"Factor V inhibitors: rare or not so uncommon A multilaboratory investigation.","volume":"15","author":"Favaloro","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R5-18-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/ard.60.5.433","article-title":"Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.","volume":"60","author":"Abu-Shakra","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R6-18-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ajh.10172","article-title":"High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.","volume":"71","author":"Bayani","year":"2002","journal-title":"Am J Hematol"},{"key":"R7-18-20210203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/1076029606293438","article-title":"Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.","volume":"12","author":"Wiwanitkit","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"R8-18-20210203","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<176::AID-AJH14>3.0.CO;2-A","article-title":"Deep vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features.","volume":"57","author":"Kamphuisen","year":"1998","journal-title":"Am J Hematol"},{"key":"R9-18-20210203","first-page":"971","article-title":"A case positive for the inhibitor for coagulation factor V.","volume":"47","author":"Nakagoshi","year":"1999","journal-title":"Rinsho Byori"},{"key":"R10-18-20210203","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00007890-199910150-00026","article-title":"Inhibitor against coagulation factor V after liver transplantation.","volume":"68","author":"Leroy-Matheron","year":"1999","journal-title":"Transplantation"},{"key":"R11-18-20210203","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1172\/JCI112318","article-title":"Isolation and study of an acquired inhibitor of human coagulation factor V.","volume":"77","author":"Nesheim","year":"1986","journal-title":"J Clin Invest"},{"key":"R12-18-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2257.1994.tb00406.x","article-title":"Development of a factor V and thrombin inhibitor following partial hepatic resection and the use of topical thrombin concentrate.","volume":"16","author":"Cruickshank","year":"1994","journal-title":"Clin Lab Haematol"},{"key":"R13-18-20210203","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI106375","article-title":"Factor V anticoagulants: clinical, biochemical and immunological observations.","volume":"49","author":"Feinstein","year":"1970","journal-title":"J Clin Invest"},{"key":"R16-18-20210203","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2169\/internalmedicine.46.6390","article-title":"Acquired factor V inhibitor responsive to corticosteroids in a patient with double cancers.","volume":"46","author":"Endo","year":"2007","journal-title":"Intern Med"},{"key":"R17-18-20210203","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2257.2006.00873.x","article-title":"Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma.","volume":"29","author":"Maughan","year":"2007","journal-title":"Int J Lab Hematol"},{"key":"R18-18-20210203","first-page":"921","article-title":"Acquired factor V inhibitor in a patient with gingival squamous cell cancer and tuberculosis.","volume":"6","author":"Chenthilmurugan","year":"2008","journal-title":"Clin Adv Hematol Oncol"},{"key":"R20-18-20210203","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10067-005-0181-2","article-title":"Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies.","volume":"25","author":"Miesbach","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R21-18-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s002770050361","article-title":"Factor V inhibitor associated with cold agglutinin disease.","volume":"76","author":"Van Spronsen","year":"1998","journal-title":"Ann Hematol"},{"key":"R23-18-20210203","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MBC.0b013e3283424883","article-title":"Inherited and acquired factor V deficiency.","volume":"22","author":"Lippi","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R24-18-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1537-2995.2002.00011.x","article-title":"Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.","volume":"42","author":"Streiff","year":"2002","journal-title":"Transfusion"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-201301000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:13:21Z","timestamp":1618035201000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201301000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328359bc59","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}